Nature's Sunshine Products, Inc. (NATR) AI Stock Analysis

Nature's Sunshine Products, Inc. is a natural health and wellness company established in 1972 and headquartered in Lehi, Utah. The company manufactures and distributes nutritional and personal care products across Asia, Europe, North America, Latin America, and other global markets. Its lineup addresses blood sugar support, bone health, cellular health, cognitive function, joint health, mood enhancement, sexual health, sleep support, sports nutrition, energy, vision care, immunity support, cardiovascular health, and digestive wellness. It also sells personal care items such as oils, lotions, shampoos, and cleansers. Offerings are marketed under the Nature's Sunshine and Synergy WorldWide brands and distributed through independent consultants.

From FY2020 to FY2025, Nature's Sunshine Products expanded revenue at a 5-year CAGR of 4.5%. Annual revenue increased from $444.1M in FY2021 to $480.1M in FY2025, rebounding from a 5.0% decline in FY2022. Operating margin contracted from 7.8% in FY2021 to 3.9% in FY2022 before recovering to 5.2% in FY2025. Net income stood at $19.5M in FY2025 with diluted earnings per share of $1.26, up from $7.7M and $0.44 in FY2024. For the trailing twelve months, revenue reached $492.0M with a profit margin of 3.7%. In the latest quarter ended June 30, 2026, quarterly revenue grew 1.9% year-over-year, while quarterly earnings declined 32.1%.

As of June 30, 2026, Nature's Sunshine Products held $82.5M in cash and short-term investments against $21.4M in total debt, creating a net cash position of $61.1M. Total assets were $259.8M compared to shareholders' equity of $169.3M. The company shows a debt-to-equity ratio of 0.13 and a current ratio of 2.60. Operating cash flow in FY2025 was $35.3M, and free cash flow reached $28.8M. In FY2025, the company deployed $6.5M toward capital expenditures and $16.3M toward share buybacks, lowering its 5-year share count by 8.8%.

At a last close of $12.64 on October 16, 2026, NATR traded at a trailing P/E of 12.5x and a forward P/E of 9.4x, below the median of its US-listed Consumer Defensive peers at 18.6x and 14.3x, respectively. Its enterprise value of $177.3M represents an EV to EBITDA multiple of 4.2x, compared to the peer median of 11.7x. The company's price to sales ratio is 0.5x versus 0.7x for peers. Over the past year, NATR returned -11.6%, while the S&P 500 (SPY) returned 16.8%. Over five years, the stock dropped 17.8% against an 83.0% gain for the index.

Consensus ratings from analysts show 2 Strong Buy ratings, with 0 Buy, 0 Hold, 0 Sell, and 0 Strong Sell ratings. The mean price target is $30.50, representing an upside of 141.3% from the last close of $12.64. For the current fiscal year ending December 31, 2026, analysts estimate revenue of $495.7M and EPS of $1.08, indicating an EPS decline of 14.3%. For FY2027, 2 analysts expect revenue of $519.2M and EPS of $1.23. The company beat EPS estimates in 3 of the last 4 quarters, and its next earnings date is November 5, 2026.

This page is an AI-written research summary of Nature's Sunshine Products, Inc. (NATR). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: NATR income statement, NATR balance sheet, NATR key metrics, NATR analyst forecast, NATR chart. See the NATR stock overview for the latest quote and news.